Sort
51,593 grants matching “hepatitis”
Mechanistic Machine Learning
$698,661David J. Albers · Columbia University Health Sciences · R01 · FY2017 · LM
PATHOGENESIS OF HEPATITIS B VIRUS IN TRANSGENIC MICE
$698,594Scripps Research Institute · R01 · FY2001 · CA
Molecular Approaches To Antiviral and Vaccine Development For Hepatitis C
$698,568Tsanyang Liang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2013 · DK
A prospective, randomized, clinical trial to evaluate two novel therapies, mycoph
$698,450Timothy Ross Morgan · Southern California Inst For Res/Educ · U01 · FY2016 · AA
Confounder-Corrected Quantitative MRI Biomarkers of Hepatic
$698,355Scott B. Reeder · University Of Wisconsin-Madison · R01 · FY2014 · DK
Epidemiology of Helicobacter Pylori Transmission
$698,295Julie Parsonnet · Stanford University · R01 · FY2009 · AI
HIV Testing in Dental Care Settings
$698,277Lisa R Metsch · University Of Miami School Of Medicine · R01 · FY2009 · DE
Protein Biomarkers for CVD Prediction in HIV-Infected and Uninfected Veterans
$698,276Priscilla Y. Hsue · University Of California, San Francisco · R01 · FY2019 · HL
Impact on opioid use of bundling medication-assisted treatment with mHealth
$698,163David H Gustafson · University Of Wisconsin-Madison · R01 · FY2016 · DA
Development and Validation of Prognostic Radiomic Markers of Response and Recurrence for Patients with Colorectal Liver Metastases
$698,152Richard Kinh Gian Do · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA
Effect of HBV DNA Methylation and the Mutant 1762T/1764A on Viral Load and HCC
$698,134Kathleen Schwarz · Johns Hopkins University · U01 · FY2012 · DK
Molecular Dynamics Simulations Of Biological Macromolecules
$698,129Bernard R Brooks · Heart, Lung, And Blood Institute · Z01 · FY2007 · HL
Biology of human cytotoxic CD4 T cells (CD4-CTLs) in viral infections
$698,113Pandurangan Vijayanand · La Jolla Institute For Immunology · U19 · FY2023 · AI
Indiana University Center for Pediatric Pharmacology and Precision Medicine
$697,951Jamie L Renbarger · Indiana University Indianapolis · P50 · FY2019 · HD
Profiling the protective B cell response to HCV
$697,946Steven Foung · Stanford University · U19 · FY2016 · AI
PUFAs and gene variation affecting aspirin antiplatelet response
$697,905Kenneth E. Thummel · University Of Washington · P01 · FY2017 · GM
Molecular Mechanisms Of Hepatitis B Viral Pathogenesis And Persistence
$697,871Tsanyang Liang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2013 · DK
Risk Factors for Venous Thromboembolism in the Community
$697,856John A Heit · Mayo Clinic Rochester · R01 · FY2010 · HL
Role of PXR in drug-elicited cardiovascular disease
$697,761Changcheng Zhou · University Of California Riverside · R01 · FY2024 · HL
HCV Disease Management in HIV-HCV Coinfected IDUs
$697,750Mark Sebastian Sulkowski · Johns Hopkins University · R01 · FY2015 · DA
Novel Biomarkers for Post-Liver Transplant NASH Fibrosis
$697,731Gavin E Arteel · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · DK
Novel Biomarkers for Post-Liver Transplant NASH Fibrosis
$697,731Gavin E Arteel · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · DK
Trial of Statins for Chemoprevention in Hepatocellular Carcinoma
$697,704Raymond T Chung · Massachusetts General Hospital · R01 · FY2022 · CA
3/4 Alcohol Research Consortium in HIV - Epidemiological Research Arm (ARCH-ERA)
$697,668Heidi M. Crane · University Of Washington · U01 · FY2017 · AA
Chicago Clinical Trials Unit
$697,341Babafemi O Taiwo · Northwestern University At Chicago · UM1 · FY2023 · AI